Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2019 Apr 8;7(7):2359–2368.e3. doi: 10.1016/j.jaip.2019.03.049

Table 5: Description of Failed Challenge Reactions.

Symptom categories were derived from PRACTALL guidelines and definitions of reactions.

Overall
(n=30)
Grade 2/3
Reaction (n=21)
Anaphylactic
Reaction (n=3)
Percent Ingested, mean (sd) 37.0 (38.3) 39.8 (41.8) 57.0 (60.8)
Reaction Symptoms: Subjective
Oral Itching 8 (27%) 3 (14%) 0 (0%)
Pruritus 8 (27%) 6 (29%) 1 (33%)
Nausea 2 (7%) 2 (10%) 0 (0%)
Abdominal Pain 3 (10%) 3 (14%) 1 (33%)
Irritability 2 (7%) 2 (10%) 0 (0%)
Dizziness 0 (0%) 0 (0%) 0 (0%)
Reaction Symptoms: Objective
Hives / Angioedema 17 (57%) 17 (81%) *** 2 (67%)
Non-urticarial Rash 3 (10%) 1 (5%) 0 (0%)
Flushing (local) 6 (20%) 3 (14%) 1 (33%)
Flushing (generalized) 0 (0%) 0 (0%) 0 (0%)
Nasal symptoms 12 (40%) 10 (48%) 3 (100%)
Wheeze 2 (7%) 2 (10%) 2 (67%)*
Laryngeal symptoms 1 (3%) 1 (5%) 0 (0%)
Vomiting 3 (10%) 3 (14%) 1 (33%)
Diarrhea 0 (0%) 0 (0%) 0 (0%)
Tachycardia 1 (3%) 1 (5%) 1 (33%)
Low blood pressure 0 (0%) 0 (0%) 0 (0%)
Reaction Treatment
Treatment given 21 (70%) 14 (67%) 3 (100%)
Antihistamines 21 (70%) 14 (67%) 3 (100%)
H2 blocker 3 (10%) 3 (14%) 2 (67%)*
Steroid 2 (7%) 2 (10%) 2 (67%)*
Albuterol 1 (3%) 1 (5%) 1 (33%)
Epinephrine 2 (7%) 2 (10%) 2 (67%)*

In this cohort, the 1 subject experiencing laryngeal symptoms had throat clearing.

*

p<0.05

**

p<0.01

***

p<0.001